Holland Capital backs LynxCare to scale its European hospital network
What's the deal? Belgian clinical informatics company LynxCare has raised a capital increase led by new investor Holland CapitalDealroom has a profile for this one. Try Dealroom →, a Dutch firm with a health tech track record. Existing backers Elaia, HERAN PartnersDealroom has a profile for this one. Try Dealroom →, b2venture, Matterwave VenturesDealroom has a profile for this one. Try Dealroom →, MTIPDealroom has a profile for this one. Try Dealroom →, and Vassoyan Conseil all participated. The amount was not disclosed.
What's the endgame? LynxCare, co-founded by Dr Dries Hens, turns hospital records into real-world evidence for research. Its small clinical language models extract detail buried in free-text physician notes — such as whether a tumour progressed or which side effects occurred — and structure it without sensitive data leaving the hospital.
The data is converted into the OMOP Common Data Model, an international standard, so the same study can run across different hospitals and countries. Researchers receive only aggregated results, not patient-level records.
Where the money goes: The funding will activate and scale LynxCare's existing hospital network and build capacity for multi-country studies. The company will keep developing its clinical language models, with a focus on oncology, and expand into new European markets.
Over the past two years, LynxCare has grown beyond Belgium, adding reference hospitals in France, Germany, and Spain. It has delivered more than a dozen real-world evidence studies and contributed to over 50 peer-reviewed publications and abstracts. It was recently named a finalist for the Prix Galien Bridges 2026.
New chair: Alongside the round, Sue Beecroft was appointed chair of the board, adding real-world evidence and healthcare-data experience as the company enters its scaling phase.
Why now? Europe is building rules for broader reuse of health data. The European Health Data Space is being phased in, with most secondary-use rules for electronic health records due to apply in 2029 — a potential tailwind for LynxCare's model of standardising hospital data while keeping it at the source.
The signal: The sector is drawing capital: Italy's Agora LabsDealroom has a profile for this one. Try Dealroom → raised €4.3 million in October 2026 for privacy-preserving clinical-data infrastructure. LynxCare's undisclosed raise is a bet on scaling an existing network rather than a headline mega-round — positioning for a regulatory shift that is still years from full effect.
Read more: heranpartners.com
Image credit: Generated with Gemini